Christian Machado

ORCID: 0000-0003-4895-2054
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Imaging and Diagnostics
  • Advanced MRI Techniques and Applications
  • Cardiovascular Function and Risk Factors
  • Neurological disorders and treatments
  • Cardiac Structural Anomalies and Repair
  • Heart Failure Treatment and Management
  • Cardiac Valve Diseases and Treatments
  • Cardiovascular Syncope and Autonomic Disorders
  • Cannabis and Cannabinoid Research
  • Surface Modification and Superhydrophobicity
  • Artificial Intelligence in Healthcare and Education
  • Lung Cancer Diagnosis and Treatment
  • Cardiac tumors and thrombi
  • Forensic Toxicology and Drug Analysis
  • ECG Monitoring and Analysis
  • Fluid Dynamics and Heat Transfer
  • Infective Endocarditis Diagnosis and Management
  • Neurotransmitter Receptor Influence on Behavior
  • Wireless Body Area Networks
  • Pericarditis and Cardiac Tamponade
  • Hematological disorders and diagnostics

Ascension Providence Hospital
2019-2024

Population Health Research Institute
2024

McMaster University
2024

Faculdade Brasil
2024

Providence Hospital
2010-2022

Wayne State University
1993-2022

Providence Hospital
2009-2022

Providence College
2010-2021

Michigan Medicine
2021

Michigan State University
2017-2019

Successful antitachycardia pacing (ATP) terminates ventricular tachycardia (VT) up to 250 bpm without the need for painful shocks in implantable cardioverter-defibrillator (ICD) patients. Fast VT (FVT) >200 is often treated by shock because of safety concerns, however. This prospective, randomized, multicenter trial compares and utility empirical ATP with FVT a broad ICD population.We randomized 634 patients 2 arms-standardized (n=313) or (n=321)-for initial therapy spontaneous FVT. ICDs...

10.1161/01.cir.0000145610.64014.e4 article EN Circulation 2004-10-19

The presence of a cardiovascular implantable electronic device has long been contraindication for the performance magnetic resonance imaging (MRI). We established prospective registry to determine risks associated with MRI at field strength 1.5 tesla patients who had pacemaker or cardioverter-defibrillator (ICD) that was "non-MRI-conditional" (i.e., not approved by Food and Drug Administration scanning).Patients in were referred clinically indicated nonthoracic tesla. Devices interrogated...

10.1056/nejmoa1603265 article EN New England Journal of Medicine 2017-02-17

Background Implantable cardioverter-defibrillators (ICDs) can terminate some ventricular tachycardias (VTs) painlessly with antitachycardia pacing (ATP). ATP has not routinely been applied for VT >188 bpm because of concerns about efficacy, risk acceleration, and delay definitive shock therapy. This prospective, multicenter study evaluated the efficacy empirical to fast (FVT; bpm). Methods Results Two hundred twenty coronary artery disease patients received ICDs standard indications....

10.1161/hc3101.093906 article EN Circulation 2001-08-14

Understanding the cellular entry pathways of synthetic biomaterials is highly important to improve overall labeling and delivery efficiency. Herein, mechanisms conjugated polymer nanoparticles (CPNs) are presented. CPNs intrinsic fluorescent materials used for various biological applications. While cause no toxicity, decreased CPN uptake observed from cancer cells pretreated with genistein, which an inhibitor caveolae-mediated endocytosis (CvME). CvME further confirmed by high...

10.1002/mabi.201300030 article EN Macromolecular Bioscience 2013-04-30

To determine whether an increased female gender susceptibility to torsades de pointes (TdP) may exist in a clinical model of bradycardia-induced long QT syndrome, we investigated reported cases TdP associated with acquired complete heart block.Seventy-two the medical literature dating from 1941 through 1993 were identified, all describing or "transient ventricular tachycardia/fibrillation" (to include those prior use terminology) setting block unassociated prolonging drugs. Expected...

10.1111/j.1540-8167.1995.tb00380.x article EN Journal of Cardiovascular Electrophysiology 1995-11-01

Many patients who need cardiac resynchronization therapy (CRT) require chronic anticoagulation. Current guidelines recommend discontinuation of warfarin and the initiation anticoagulant "bridging" during these procedures. We evaluated safety CRT-device (CRT-D) implantation without interruption therapy.A total 123 consecutive requiring CRT-D were enrolled, 49 identified as high risk for thromboembolic events received either intravenous heparin, low molecular weight or therapy. The control...

10.1111/j.1540-8159.2010.02703.x article EN Pacing and Clinical Electrophysiology 2010-02-18

The incidence of conduction disease requiring permanent pacemaker (PPM) implantation following aortic valve replacement (AVR) ranges from 3% to 6%. Data concerning the potential risks for PPM requirement associated with certain types have been conflicting and controversial. We sought evaluate prevalence, predictors implantation, dependency during follow-up in patients undergoing AVR.A total 214 consecutive AVR were studied retrospectively. A 207 included statistical analysis. Clinical...

10.1111/j.1540-8159.2009.02552.x article EN Pacing and Clinical Electrophysiology 2009-10-05

Wearable devices may be useful for identification, quantification and characterization, management of atrial fibrillation (AF). To date, consumer wrist-worn AF detection using photoplethysmography-based algorithms perform only periodic checks when the user is stationary are US Food Drug Administration cleared prediagnostic uses without intended use clinical decision-making. There an unmet need medical-grade diagnostic that provide long-term, continuous monitoring.

10.1161/jaha.123.030543 article EN Journal of the American Heart Association 2023-09-26

Left ventricular (LV) remodeling has been attributed to the segmental loss of viable myocardium due myocardial infarction (MI), which results in redistribution cardiac workload, with increased regional wall stress and around infarct zone. Because pacing shown reduce workload regions near site, this trial was designed test whether chronic attenuates LV remodeling.Eighty patients an anterior MI, peak creatine kinase >2000 mU/mL, ejection fraction ≤35%, motion abnormality (WMA) >5 16 segments,...

10.1161/circheartfailure.110.945881 article EN Circulation Heart Failure 2010-09-18

Background In the current age of ever‐increasing healthcare costs, it is utmost importance to adopt strategies that reduce hospital stay and cost, while still maintaining patient safety. this study we review our approach same‐day discharge following implantable cardioverter defibrillator (ICD) placement for primary prevention sudden cardiac death (SCD). Methods We conducted a retrospective chart 415 consecutive patients who underwent ICD implantation SCD between 2007 2010. Patients were...

10.1111/pace.12145 article EN Pacing and Clinical Electrophysiology 2013-04-25

Background: Patients with implantable devices are generally not permitted to undergo magnetic resonance imaging (MRI) because of potentially deleterious interactions. Little has been reported regarding the safety and effects MRI scanning patients loop recorders (ILRs). We evaluated ILRs output ILR after undergoing MRI. Methods: Ten underwent 11 events. All had Reveal Plus (Medtronic, Minneapolis, MN) ILRs. Seven cranial, two lumbar‐spine, one shoulder, knee were performed. MRIs performed...

10.1111/j.1542-474x.2005.00056.x article EN Annals of Noninvasive Electrocardiology 2005-10-01

10.1016/j.jelectrocard.2015.10.003 article EN Journal of Electrocardiology 2015-10-21

Abstract Introduction Leadless pacemaker (LP) is a novel that has been proven to be effective and safe; however, the majority of LPs in previous reports were Medtronic Micra™ VR LP. We aim evaluate implant efficiency clinical performance Aveir™ LP compared Method performed retrospective analysis two healthcare systems (Sparrow Hospital Ascension Health System, Michigan) patients implanted with between January 1, 2018, April 2022. The parameters collected at implantation, 3 months 6 months....

10.1111/pace.14766 article EN Pacing and Clinical Electrophysiology 2023-06-29

Introduction: Patients in underdeveloped nations have limited access to life‐saving medical technology including cardiac rhythm management (CRM) devices. We evaluated alternative means provide such this patient population while assessing the safety and efficacy of a practice. Methods: United States with clinical indications for extraction CRM devices were consented. Antemortem cleaned sterilized following protocol established at our institution. Surveillance vitro cultures performed quality...

10.1111/j.1540-8159.2011.03061.x article EN Pacing and Clinical Electrophysiology 2011-03-21

In patients with cardiac sarcoidosis, the sarcoid granulomas usually involve myocardium or endocardium. The disease typically presents as heart failure ventricular arrhythmias, conduction disturbances, both. Constrictive pericarditis has rarely been described in sarcoidosis: we found only 2 reports of this association. We report case a 57-year-old man who presented clinical and hemodynamic features constrictive pericarditis, unclear cause. He was admitted for treatment recurrent pleural...

10.14503/thij-13-3208 article EN Texas Heart Institute Journal 2014-06-01
Coming Soon ...